These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1354 related items for PubMed ID: 28453491

  • 21. Evaluation and Characterization of Modified K114 Method to Localize Plaques in Rodent and Plaques and Tangles in Human Brain Tissue.
    Padala S, Setti S, Raymick J, Hanig J, Sarkar S.
    Curr Alzheimer Res; 2024; 21(1):69-80. PubMed ID: 38566375
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Dual enhancement of double immunofluorescent signals by CARD: participation of ubiquitin during formation of neurofibrillary tangles.
    Uchihara T, Nakamura A, Nagaoka U, Yamazaki M, Mori O.
    Histochem Cell Biol; 2000 Dec; 114(6):447-51. PubMed ID: 11201605
    [Abstract] [Full Text] [Related]

  • 24. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR, Fändrich M.
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract] [Full Text] [Related]

  • 25. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS.
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [Abstract] [Full Text] [Related]

  • 26. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation.
    Tanabe Y, Ishizu H, Ishiguro K, Itoh N, Terada S, Haraguchi T, Kawai K, Kuroda S.
    Neuroreport; 2000 Aug 03; 11(11):2473-7. PubMed ID: 10943706
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine.
    Rofina JE, Singh K, Skoumalova-Vesela A, van Ederen AM, van Asten AJ, Wilhelm J, Gruys E.
    Amyloid; 2004 Jun 03; 11(2):90-100. PubMed ID: 15478464
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ, Braak H, Xue QS, Bechmann I.
    Acta Neuropathol; 2009 Oct 03; 118(4):475-85. PubMed ID: 19513731
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
    den Haan J, Morrema THJ, Rozemuller AJ, Bouwman FH, Hoozemans JJM.
    Acta Neuropathol Commun; 2018 Aug 09; 6(1):75. PubMed ID: 30092839
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.
    Gallardo G, Holtzman DM.
    Adv Exp Med Biol; 2019 Aug 09; 1184():187-203. PubMed ID: 32096039
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain.
    Wilhelmus MM, Grunberg SC, Bol JG, van Dam AM, Hoozemans JJ, Rozemuller AJ, Drukarch B.
    Brain Pathol; 2009 Oct 09; 19(4):612-22. PubMed ID: 18673368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 68.